The Worldwide Digital Therapeutic (DTx) Industry is Expected to Reach $47.9 by 2027 – PR Newswire

Share Article

Searching for your content…
In-Language News
Contact Us
from 8 AM – 10 PM ET
News provided by
Jul 04, 2022, 13:30 ET
Share this article
DUBLIN, July 4, 2022 /PRNewswire/ — The "Global Digital Therapeutic (DTx) Market (2022-2027) by Component, Indication, Distribution, Geography, Competitive Analysis, and the Impact of Covid-19 with Ansoff Analysis" report has been added to’s offering.
The Global Digital Therapeutic (DTx) Market is estimated to be USD 12.84 Bn in 2022 and is projected to reach USD 47.93 Bn by 2027, growing at a CAGR of 30.14%.

 Market Dynamics
Market dynamics are forces that impact the prices and behaviors of the Global Digital Therapeutic (DTx) Market stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors. There are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals.

As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.
Company Profiles
The report provides a detailed analysis of the competitors in the market. It covers the financial performance analysis for the publicly listed companies in the market. The report also offers detailed information on the companies’ recent development and competitive scenario. Some of the companies covered in this report are 2Morrow, Akili Interactive Labs, Ayogo Health, Better Therapeutics, BigHealth, Canary Health, Click Therapeutics, Cognoa, Ginger, Happify, Kaia Health, Omada Health, Welldoc, etc.

 Countries Studied
Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.

Ansoff Analysis
 Why buy this report?
Key Topics Covered:

1 Report Description

2 Research Methodology

3 Executive Summary

4 Market Dynamics
4.1 Drivers
4.1.1 Increasing Incidence of Preventable Chronic Diseases
4.1.2 Increasing mHealth Penetration
4.1.3 Control on Healthcare Cost with Focus on Preventive Healthcare
4.2 Restraints
4.2.1 Limited Awareness Regarding Digital Therapeutics in the Developing Countries
4.3 Opportunities
4.3.1 Huge Undiagnosed and Untreated Population Base
4.3.2 R & D in Therapeutic Applications
4.4 Challenges
4.4.1 Patient Data Privacy Concerns
4.4.2 Reluctance among Patients to adopt Digital Therapeutics

5 Market Analysis
5.1 Regulatory Scenario
5.2 Porter’s Five Forces Analysis
5.3 Impact of COVID-19
5.4 Ansoff Matrix Analysis

6 Global Digital Therapeutic (DTx) Market, By Component
6.1 Introduction
6.2 Devices
6.3 Software

7 Global Digital Therapeutic (DTx) Market, By Indication
7.1 Introduction
7.2 Cardiovascular Disease
7.3 Central Nervous System Disorder
7.4 Chronic Respiratory Disease
7.5 Diabetes
7.6 Medication Adherence
7.7 Musculoskeletal Disorder
7.8 Obesity
7.9 Smoking Cessation

8 Global Digital Therapeutic (DTx) Market, By Distribution
8.1 Introduction
8.2 B2B
8.2.1 Employer
8.2.2 Payer
8.2.3 Pharmaceutical Company
8.2.4 Provider
8.3 B2C
8.3.1 Caregiver
8.3.2 Patient

9 Americas’ Digital Therapeutic (DTx) Market
9.1 Introduction
9.2 Argentina
9.3 Brazil
9.4 Canada
9.5 Chile
9.6 Colombia
9.7 Mexico
9.8 Peru
9.9 United States
9.10 Rest of Americas

10 Europe’s Digital Therapeutic (DTx) Market
10.1 Introduction
10.2 Austria
10.3 Belgium
10.4 Denmark
10.5 Finland
10.6 France
10.7 Germany
10.8 Italy
10.9 Netherlands
10.10 Norway
10.11 Poland
10.12 Russia
10.13 Spain
10.14 Sweden
10.15 Switzerland
10.16 United Kingdom
10.17 Rest of Europe

11 Middle East and Africa’s Digital Therapeutic (DTx) Market
11.1 Introduction
11.2 Egypt
11.3 Israel
11.4 Qatar
11.5 Saudi Arabia
11.6 South Africa
11.7 United Arab Emirates
11.8 Rest of MEA

12 APAC’s Digital Therapeutic (DTx) Market
12.1 Introduction
12.2 Australia
12.3 Bangladesh
12.4 China
12.5 India
12.6 Indonesia
12.7 Japan
12.8 Malaysia
12.9 Philippines
12.10 Singapore
12.11 South Korea
12.12 Sri Lanka
12.13 Thailand
12.14 Taiwan
12.15 Rest of Asia-Pacific

13 Competitive Landscape
13.1 Competitive Quadrant
13.2 Market Share Analysis
13.3 Strategic Initiatives
13.3.1 M&A and Investments
13.3.2 Partnerships and Collaborations
13.3.3 Product Developments and Improvements

14 Company Profiles
14.1 2Morrow
14.2 Akili Interactive Labs
14.3 Ayogo Health
14.4 Better Therapeutics
14.5 BigHealth
14.6 Canary Health
14.7 Click Therapeutics
14.8 Cognoa
14.9 Ginger
14.10 Happify
14.11 Kaia Health
14.12 Omada Health
14.13 Welldoc

15 Appendix
For more information about this report visit
Media Contact:
Research and Markets 
Laura Wood, Senior Manager 
[email protected]  
For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630 
For GMT Office Hours Call +353-1-416-8900 
U.S. Fax: 646-607-1907 
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET


You might also like

Surviving 2nd wave of corona

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort